MedTrace Logo

Type 2 Diabetes, Obesity and Cortisol Excess

NCT05759637 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3200

Last updated 2025-03-24

No results posted yet for this study

Summary

The present observational cross-sectional study is aimed to assess: the hidden hypercortisolism (HidHyCo) prevalence in a sample of Type 2 diabetes (T2D) patients and the clinical characteristics more frequently associated with the HidHyCo presence and the HidHyCo prevalence in an adequate sample of obese patients without T2D and the clinical characteristics more frequently associated with the HidHyCo presence.

Conditions

  • Diabetes Mellitus, Type 2
  • Obesity
  • Cortisol; Hypersecretion

Interventions

DIAGNOSTIC_TEST

1mg DST

measurement of cortisol levels after 1 mg of dexamethasone (DST) at 11 pm

Sponsors & Collaborators

  • University of Siena

    collaborator OTHER

  • Niguarda Hospital

    collaborator OTHER

  • Campus Bio-Medico University

    collaborator OTHER

  • Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine, Italy

    collaborator OTHER

  • Istituto Auxologico Italiano

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-06
Primary Completion
2025-12-06
Completion
2025-12-06

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05759637 on ClinicalTrials.gov